The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Herpes Simplex Virus (HSV) Vaccines Market Research Report 2024
Synopsis
Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts.
The global Herpes Simplex Virus (HSV) Vaccines market was valued at US$ 841 million in 2023 and is anticipated to reach US$ 1294.2 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Herpes Simplex Virus (HSV) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Simplex Virus (HSV) Vaccines.
Report Scope
The Herpes Simplex Virus (HSV) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Herpes Simplex Virus (HSV) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Simplex Virus (HSV) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GlaxoSmithKline
Genocea Biosciences
Vical
Segment by Type
GEN-003
VCL-HB01
HSV529
Others
Segment by Application
HSV-1 (Oral Herpes)
HSV-2 (Genital Herpes)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Herpes Simplex Virus (HSV) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Herpes Simplex Virus (HSV) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts.
The global Herpes Simplex Virus (HSV) Vaccines market was valued at US$ 841 million in 2023 and is anticipated to reach US$ 1294.2 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Herpes Simplex Virus (HSV) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Simplex Virus (HSV) Vaccines.
Report Scope
The Herpes Simplex Virus (HSV) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Herpes Simplex Virus (HSV) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Simplex Virus (HSV) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GlaxoSmithKline
Genocea Biosciences
Vical
Segment by Type
GEN-003
VCL-HB01
HSV529
Others
Segment by Application
HSV-1 (Oral Herpes)
HSV-2 (Genital Herpes)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Herpes Simplex Virus (HSV) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Herpes Simplex Virus (HSV) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Herpes Simplex Virus (HSV) Vaccines Market Overview
1.1 Product Overview and Scope of Herpes Simplex Virus (HSV) Vaccines
1.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type
1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Herpes Simplex Virus (HSV) Vaccines Segment by Application
1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Value by Application: (2024-2030)
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Global Herpes Simplex Virus (HSV) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue 2019-2030
1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales 2019-2030
1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Herpes Simplex Virus (HSV) Vaccines Market Competition by Manufacturers
2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Herpes Simplex Virus (HSV) Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Herpes Simplex Virus (HSV) Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Product Type & Application
2.7 Herpes Simplex Virus (HSV) Vaccines Market Competitive Situation and Trends
2.7.1 Herpes Simplex Virus (HSV) Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue
2.7.3 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario by Region
3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Herpes Simplex Virus (HSV) Vaccines Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2019-2030
3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2019-2024
3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2025-2030
3.3 Global Herpes Simplex Virus (HSV) Vaccines Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2019-2030
3.3.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2019-2024
3.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2025-2030
3.4 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.4.1 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2030)
3.4.3 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.5.1 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2030)
3.5.3 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2019-2030)
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2019-2024)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2025-2030)
4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2019-2030)
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2019-2024)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2025-2030)
4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2019-2030)
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2019-2024)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2025-2030)
5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2019-2030)
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2019-2024)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2025-2030)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Genocea Biosciences
6.3.1 Genocea Biosciences Corporation Information
6.3.2 Genocea Biosciences Description and Business Overview
6.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.3.5 Genocea Biosciences Recent Developments/Updates
6.4 Vical
6.4.1 Vical Corporation Information
6.4.2 Vical Description and Business Overview
6.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.4.5 Vical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Herpes Simplex Virus (HSV) Vaccines Industry Chain Analysis
7.2 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process
7.4 Herpes Simplex Virus (HSV) Vaccines Sales and Marketing
7.4.1 Herpes Simplex Virus (HSV) Vaccines Sales Channels
7.4.2 Herpes Simplex Virus (HSV) Vaccines Distributors
7.5 Herpes Simplex Virus (HSV) Vaccines Customers
8 Herpes Simplex Virus (HSV) Vaccines Market Dynamics
8.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
8.2 Herpes Simplex Virus (HSV) Vaccines Market Drivers
8.3 Herpes Simplex Virus (HSV) Vaccines Market Challenges
8.4 Herpes Simplex Virus (HSV) Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Herpes Simplex Virus (HSV) Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Herpes Simplex Virus (HSV) Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2019-2024)
Table 59. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2025-2030)
Table 60. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2019-2024)
Table 69. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Herpes Simplex Virus (HSV) Vaccines Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Genocea Biosciences Corporation Information
Table 81. Genocea Biosciences Description and Business Overview
Table 82. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product
Table 84. Genocea Biosciences Recent Developments/Updates
Table 85. Vical Corporation Information
Table 86. Vical Description and Business Overview
Table 87. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Vical Herpes Simplex Virus (HSV) Vaccines Product
Table 89. Vical Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 93. Herpes Simplex Virus (HSV) Vaccines Customers List
Table 94. Herpes Simplex Virus (HSV) Vaccines Market Trends
Table 95. Herpes Simplex Virus (HSV) Vaccines Market Drivers
Table 96. Herpes Simplex Virus (HSV) Vaccines Market Challenges
Table 97. Herpes Simplex Virus (HSV) Vaccines Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Herpes Simplex Virus (HSV) Vaccines
Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2023 & 2030
Figure 4. GEN-003 Product Picture
Figure 5. VCL-HB01 Product Picture
Figure 6. HSV529 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2023 & 2030
Figure 10. HSV-1 (Oral Herpes)
Figure 11. HSV-2 (Genital Herpes)
Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Market Size (2019-2030) & (US$ Million)
Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Sales (2019-2030) & (K Units)
Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 16. Herpes Simplex Virus (HSV) Vaccines Report Years Considered
Figure 17. Herpes Simplex Virus (HSV) Vaccines Sales Share by Manufacturers in 2023
Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Herpes Simplex Virus (HSV) Vaccines Players: Market Share by Revenue in 2023
Figure 20. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2019-2030)
Figure 23. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2019-2030)
Figure 27. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2019-2030)
Figure 28. Germany Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2019-2030)
Figure 35. China Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Herpes Simplex Virus (HSV) Vaccines by Type (2019-2030)
Figure 56. Global Revenue Market Share of Herpes Simplex Virus (HSV) Vaccines by Type (2019-2030)
Figure 57. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Herpes Simplex Virus (HSV) Vaccines by Application (2019-2030)
Figure 59. Global Revenue Market Share of Herpes Simplex Virus (HSV) Vaccines by Application (2019-2030)
Figure 60. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 61. Herpes Simplex Virus (HSV) Vaccines Value Chain
Figure 62. Herpes Simplex Virus (HSV) Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
